Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Filings indexed 1,687 across all filing types
Latest filing 2024-07-08 Fund Information / Fact…
Country TW Taiwan
Listing TW 1786

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
113年6月營業收入
Fund Information / Factsheet Classification · 95% confidence The document is a summary report of monthly and cumulative revenue figures for a company named 科妍, presented in a tabular format with explanations about accounting standards and revenue recognition. It contains no detailed financial statements, no management discussion, no audit opinions, no legal or regulatory announcements, and no meeting or voting information. The document length is short (765 characters) and it appears to be a brief financial data summary rather than a full report or announcement. It does not fit the criteria for Annual Report, Interim Report, Earnings Release, or any other detailed report types. It is essentially a brief factsheet summarizing key financial figures for a period (June 2024). Therefore, the best fitting category is Fund Information / Factsheet (FS), which covers brief summaries of key company facts and financials.
2024-07-08 Chinese
113年06月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, managers, and their related parties. It shows changes in shareholdings, types of shares held, and other related information. This type of document is typical of a Director's Dealing report, which discloses personal share transactions by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document is not an announcement of a report but contains substantive data on insider shareholdings. Therefore, the appropriate classification is Director's Dealing (DIRS).
2024-07-02 Chinese
113年06月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabular disclosure of shareholdings by company insiders, including directors and senior management, showing their current holdings, pledged shares, and related information. It is a typical insider shareholding disclosure report. There is no indication of financial results, earnings, management discussion, or regulatory certifications. The document is not an announcement of a report but a direct disclosure of insider shareholdings. This fits the definition of Director's Dealing (DIRS), which covers reports of personal share transactions or holdings by company directors and executives. The document length is short (2484 characters), but it contains substantive data on insider holdings, not just an announcement or certification. Therefore, the correct classification is DIRS with high confidence.
2024-07-02 Chinese
公告本公司除息基準日
Notice of Dividend Amount Classification · 100% confidence The document is a short announcement (888 characters) regarding the company's dividend distribution details, including the ex-dividend date, dividend amount per share, and related dates. It does not contain financial statements or detailed financial analysis but rather provides specific dividend payment information. This fits the definition of a Notice of Dividend Amount (DIV) filing, which announces dividend amounts, payment dates, and details for shareholders. The document is not a full report but a specific dividend announcement.
2024-06-26 Chinese
公告本公司113年股東常會重要決議事項
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a short announcement (612 characters) reporting the important resolutions from the company's Annual General Meeting (AGM) held on 113/06/26 (Taiwanese calendar year). It lists decisions such as approval of earnings distribution, amendments to company articles, approval of business report and financial statements, and notes no election of directors or supervisors. The document is not the full AGM materials or minutes but an official announcement of the voting results and resolutions passed at the AGM. According to the filing definitions, announcements of shareholder vote results at general meetings fall under Declaration of Voting Results & Voting Rights Announcements (DVA). The document is not a full Annual Report or AGM presentation, and it is not a report publication announcement since it contains substantive resolution details. Therefore, the correct classification is DVA with high confidence.
2024-06-26 Chinese
113年5月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (科妍) reporting on the status of fund loans and endorsement guarantees for the current and previous month, including cumulative amounts and limits. It contains tabulated financial data but is very short (601 characters) and focuses on specific financial guarantees and loans rather than comprehensive financial statements or management discussion. There is no indication of a full annual or interim report, audit report, or earnings release. The content is a regulatory disclosure of financial status related to guarantees and loans, which fits best under Regulatory Filings (RNS) as it is a general regulatory announcement without the depth of a full financial report.
2024-06-07 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.